Guillain‐Barré syndrome associated with Coronavirus disease 2019: A case from Nepal

Abstract

Coronavirus disease 2019 (COVID‐19) has now spread widely after the outbreak since December 31, 2019. Guillain‐Barré syndrome is an immunological postinfectious neuropathy, which has been reported to be a rare but possible complication COVID‐19. We report a case of Guillain‐Barré syndrome associated with COVID‐19 in Nepal.

Guillain-Barre syndrome associated with COVID-19 and malaria coinfection: A case report

“…33 It is the most common cause of acute flaccid paralysis, associated with an antecedent infection, especially viral infections. 4,32 Other causative agents include bacterial infections such as Mycoplasma;Campylobacter jejuni , Haemophilus influenza , andRickettsia rickettsi are well-recognized bacterial agents. 3 Furthermore, GBS has been reported to be associated with parasitic infections including Leishmania donovani , Plasmodium falciparum, and P. vivax.…”

“…Several microbes including parasites, bacterial, and viral infection are associated with developing GPS including diseases of high prevalence such as malaria,Campylobacter jejuni infection, Zika virus, and recently COVID-19. [3][4][5][6] Additionally, the development of GBS is associated with several arboviral diseases including Chikungunya, Crimean-Congo hemorrhagic fever (CCHF), dengue, Rift Valley fever, and West Nile virus. [6][7][8][9][10] Other viral infection such as hepatitis E virus, Epstein-Barr virus (EBV), cytomegalovirus (CMV) were involved in the development of GBS.…”